18
A.Baur & Co. (Pvt.) Ltd, has appointed Gehan Seneviratne as its new Board Director Alternate.
Seneviratne will continue to serve as the Director of Baur Life Sciences, a subsidiary of A. Baur & Co. His dual responsibilities underscore his pivotal role in steering both organisations towards sustained growth and innovation.
His professional journey is further distinguished by his diverse experiences at GlaxoSmithKline, Merck Sharpe & Dohme, and Baur Life Sciences, showcasing his deep expertise and strong leadership in the pharmaceutical industry.
